2171
COM:CARSGEN
CARsgen Therapeutics
- Stock
Last Close
6.71
08/11 08:08
Market Cap
2.36B
Beta: -
Volume Today
85.30M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|
average inventory | 341.50K - | |||||
average payables | ||||||
average receivables | 11.32M - | |||||
book value per share | -1.29 - | -2.95 128.79% | 7.75 362.21% | 4.48 42.12% | 3.24K 72,160.36% | |
capex per share | -0.18 - | -0.03 81.89% | -0.46 1,296.99% | -0.25 45.53% | -17.17 6,733.18% | |
capex to depreciation | -5.29 - | -0.47 91.16% | -3.40 628.45% | -1.70 50.04% | -0.11 93.57% | |
capex to operating cash flow | 0.58 - | 0.06 89.02% | 0.35 448.74% | 0.22 38.12% | 0.02 90.26% | |
capex to revenue | -6.91 - | |||||
cash per share | 0.17 - | 1.84 981.07% | 7.77 322.84% | 4.11 47.11% | 3.33K 80,797.64% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 0.26 - | 0.08 69.11% | 0.10 20.60% | 0.04 55.17% | 0.04 12.67% | |
debt to equity | -0.12 - | -0.06 48.03% | 0.11 288.59% | 0.05 57.19% | 0.05 2.06% | |
dividend yield | ||||||
earnings yield | -0.02 - | -0.13 528.44% | -0.55 333.80% | -0.12 77.85% | -0.24 95.19% | |
enterprise value | 15.17B - | 13.36B 11.92% | 8.33B 37.66% | 5.22B 37.31% | -1.76B 133.73% | |
enterprise value over ebitda | -73.49 - | -46.69 36.47% | -16.08 65.55% | -6.58 59.11% | 2.46K 37,534.68% | |
ev to operating cash flow | -84.74 - | -45.27 46.58% | -16.26 64.09% | -8.12 50.06% | 3.87 147.68% | |
ev to sales | 322.67 - | |||||
free cash flow per share | -0.50 - | -0.55 11.12% | -1.79 222.77% | -1.42 20.65% | -835.22 58,841.89% | |
free cash flow yield | -0.02 - | -0.02 17.94% | -0.08 262.56% | -0.11 33.31% | -146.78 138,290.58% | |
graham net net | -1.70 - | -3.33 96.17% | 6.46 294.15% | 3.59 44.46% | 2.54K 70,671.30% | |
graham number | 3.95 - | 14.53 268.07% | 46.24 218.22% | 12.77 72.37% | 313.08 2,350.95% | |
income quality | 0.68 - | 0.28 58.92% | 0.11 61.01% | 0.72 567.31% | 0.61 15.66% | |
intangibles to total assets | 0.11 - | 0.02 77.68% | 0.01 68.39% | 0.01 0.51% | 0.01 12.23% | |
interest coverage | -256.37 - | -24.26 90.54% | -53.91 122.22% | -56.78 5.32% | ||
interest debt per share | 0.15 - | 0.20 33.47% | 0.90 349.92% | 0.24 72.87% | 153.24 62,531.02% | |
inventory turnover | ||||||
invested capital | -0.12 - | -0.06 48.03% | 0.11 288.59% | 0.05 57.19% | 0.05 2.06% | |
market cap | 15.18B - | 14.30B 5.78% | 8.68B 39.30% | 7.37B 15.11% | 3.16M 99.96% | |
net current asset value | -943.41M - | -1.87B 98.66% | 2.56B 236.69% | 2.01B 21.50% | 1.42B 29.51% | |
net debt to ebitda | 0.06 - | 3.29 5,496.13% | 0.68 79.29% | 2.71 296.79% | 2.47K 91,034.17% | |
net income per share | -0.54 - | -3.18 492.13% | -12.26 286.19% | -1.62 86.81% | -1.34 16.87% | |
operating cash flow per share | -0.32 - | -0.52 64.88% | -1.32 154.58% | -1.17 11.98% | -818.04 70,074.33% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | 19.44 - | |||||
return on tangible assets | -1.05 - | -1.47 40.53% | -1.36 7.40% | -0.33 76.14% | -0.00 99.90% | |
revenue per share | 0.07 - | |||||
roe | 0.42 - | 1.07 158.81% | -1.58 247.28% | -0.36 77.21% | -0.00 99.88% | |
roic | 0.41 - | 0.36 13.07% | -0.17 147.85% | -0.33 91.59% | -0.00 99.87% | |
sales general and administrative to revenue | 2.55 - | |||||
shareholders equity per share | -1.29 - | -2.95 128.79% | 7.75 362.21% | 4.48 42.12% | 3.24K 72,160.36% | |
stock based compensation to revenue | 0.52 - | |||||
tangible asset value | -768.07M - | -1.71B 122.19% | 2.97B 274.02% | 2.45B 17.43% | 1.79B 27.14% | |
tangible book value per share | -1.35 - | -3.01 122.19% | 7.68 355.22% | 4.45 42.10% | 3.21K 72,170.13% | |
working capital | -906.37M - | 910.56M 200.46% | 2.68B 194.51% | 2.13B 20.59% | 1.68B 21.26% |
All numbers in (except ratios and percentages)